TrialWorld journal of urology2025

Technological innovation of HoLEP: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Zhixiang Gao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.